Creative Ventures

Controlling spiraling healthcare costs stemming from aging and chronic disease

Feeding the world sustainably with continued population and standard of living growth

Lowering carbon impact and providing the resources needed to continue growth, sustainably

We back founders creating applicable solutions to real-life, global-scale problems

Our portfolio companies have a deep technical foundation combined with unique market insight

Hard problems require multiple perspectives We’ve backed many investments with underrepresented founders, female founders, and PhD-turned founders

We believe our market-first approach and strict investment protocols are the surest way to secure exponential growth opportunities while mitigating the biggest risks investing in deep technology

We’re not in the business of predicting the future We don’t take on R&D risks with unknown horizons We invest in scalable technologies primed to meet existing market demand

We are the most rigorous manager in VC because the sectors we invest in require it Our managing partners and GPs include financial analysts, operators, industrialists, and PhD technologists with deep subject-matter expertise

• 2023 will be a recording breaking year for VC VC investments and valuations plummeted in 2022
• Here’s what that means for 2023: Read More…

2023 will be a recording breaking year for VC

VC investments and valuations plummeted in 2022 Here’s what that means for 2023:

• 3 Takeaways from the 2023 JP Morgan Healthcare Conference  by Kulika Weizman Principal Kulika reflects on the in-person conference, her panels, and more
• 2023 will be a recording breaking year for VC by Champ VC investments and valuations plummeted in 2022
• Here’s what that means for 2023:
• Reflecting on BioFuture & value-based care by Kulika Weizman Principal Kulika’s reflections on BioFuture and whether the value-based care model is investible